Inflammation, Proinflammatory Mediators and Myocardial Ischemia-reperfusion Injury

Hematology/Oncology Clinics of North America

Volumn 21, Issue 1, 2007, Pages 123-145

  Vinten Johansen, Jakob ^a   Jiang, Rong ^a   Reeves, James G ^b   Mykytenko, James ^b   Deneve, Jeremiah ^a   Jobe, Lynetta J ^c  

^a Carlyle Fraser Heart Center   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MERCER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; APROTININ; AUTACOID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; FIBRINOGEN RECEPTOR ANTAGONIST; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NEUTROPHIL INHIBITORY FACTOR; NITRIC OXIDE; PROTEINASE ACTIVATED RECEPTOR 2; REACTIVE OXYGEN METABOLITE; SODIUM PROTON EXCHANGE PROTEIN; STREPTOKINASE; THROMBIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR;

ATTENUATION; CORONARY ARTERY PRESSURE; DRUG MEGADOSE; FLOW RATE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INFLAMMATION; INFLAMMATORY CELL; LABORATORY TEST; LOW DRUG DOSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULSATILE FLOW; REPERFUSION INJURY; REVIEW; TEMPERATURE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY;

EID: 33846506801     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2006.11.010     Document Type: Review

References (156)

1. Reimer K.A., Lowe J.E., Rasmussen M.M., et al. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56 (1977) 786-794
2. DeWood M.A., Spores J., and Notske R. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303 (1980) 897-902
3. Kloner R.A., and Rezkalla S.H. Cardiac protection during acute myocardial infarction: where do we stand in 2004?. J Am Coll Cardiol 44 (2004) 276-286
4. Becker L.C., and Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis 30 (1987) 23-44
5. 2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol 280 (2001) H2649-H2657
6. Lucchesi B.R. Myocardial reperfusion injury-role of free radicals and mediators of inflammation. In: Sperelakis N., Kurachi Y., Terzic A., et al. (Eds). Heart physiology and pathophysiology. 4th edition (2001), Academic Press, San Diego (CA) 1181-1210
7. Quintana M., Kahan T., and Hjemdahl P. Pharmacological prevention of reperfusion injury in acute myocardial infarction a potential role for adenosine as a therapeutic agent. Am J Cardiovasc Drugs 4 (2004) 159-167
8. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61 (2004) 481-497
9. Vinten-Johansen J., Johnston W.E., Mills S.A., et al. Reperfusion injury after temporary coronary occlusion. J Thorac Cardiovasc Surg 95 (1988) 960-968
10. Vinten-Johansen J., Yellon D.M., and Opie L.H. A simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation 112 (2005) 2085-2088
11. Vinten-Johansen J., Zhao Z.-Q., Jiang R., et al. Myocardial protection in reperfusion with postconditioning. Expert Rev Cardiovasc Ther 3 (2005) 1035-1045
12. Moens A.L., Claeys M.J., Timmermans J.P., et al. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 100 (2005) 179-190
13. Jennings R.B., Sommers H.M., Smyth G.A., et al. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol Lab Med 70 (1960) 68-78
14. Braunwald E., and Kloner R.A. Myocardial reperfusion: a double-edged sword?. J Clin Invest 76 (1985) 1713-1719
15. Vinten-Johansen J. Reperfusion injury: idle curiosity or therapeutic vector?. J Thromb Thrombolysis 4 (1997) 59-61
16. Cobbaert C., Hermens W.T., Kint P.P., et al. Thrombolysis-induced coronary reperfusion causes acute and massive interstitial release of cardiac muscle cell proteins. Cardiovasc Res 33 (1997) 147-155
17. Kloner R.A. Does reperfusion injury exist in humans?. [review]. J Am Coll Cardiol 21 (1993) 537-545
18. Staat P., Rioufol G., Piot C., et al. Postconditioning the human heart. Circulation 112 (2005) 2143-2148
19. Cooley D.A., Ruel G.J., and Wukasch D.C. Ischemic contracture of the heart: "Stone Heart". Am J Cardiol 29 (1972) 575-577
20. Weman S.M., Karhunen P.J., Penttila A., et al. Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting. Ann Thorac Surg 70 (2000) 807-812
21. Buckberg G.D. Strategies and logic of cardioplegic delivery to prevent, avoid, and reverse ischemic and reperfusion damage. J Thorac Cardiovasc Surg 93 (1987) 127-139
22. Powell Jr. W.J., DiBona D.R., Flores J., et al. The protective effect of hyperosmotic mannitol in myocardial ischemia and necrosis. Circulation 54 (1976) 603-615
23. Reynolds R.D., Burmeister W.E., Gorczynski R.J., et al. Effects of propranolol on myocardial infarct size with and without coronary artery reperfusion in the dog. Cardiovasc Res 15 (1981) 411-420
24. Follette D.M., Fey K., Buckberg G.D., et al. Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarity. J Thorac Cardiovasc Surg 82 (1981) 221-238
25. Follette D.M., Mulder D.G., Maloney Jr. J.V., et al. Advantages of blood cardioplegia over continuous coronary perfusion and intermittent ischemia. J Thorac Cardiovasc Surg 76 (1978) 604-617
26. Vinten-Johansen J., Edgerton T.A., Howe H.R., et al. Immediate functional recovery and avoidance of reperfusion injury with surgical revascularization of short-term coronary occlusion. Circulation 72 (1985) 431-439
27. Bulkley B.H., and Hutchins G.M. Myocardial consequences of coronary artery bypass graft surgery. The paradox of necrosis in areas of revascularization. Circulation 56 (1977) 906-913
28. Miki T., Liu G.S., Cohen M.V., et al. Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction. Basic Res Cardiol 93 (1998) 372-383
29. Schwartz D.S., Bremner R.M., Baker C.J., et al. Regional topical hypothermia of the beating heart: preservation of function and tissue. Ann Thorac Surg 73 (2001) 804-809
30. Pisarenko O.I., Shulzhenko V.S., Studneva I.M., et al. Effects of gradual reperfusion on postischemic metabolism and functional recovery of isolated guinea pig heart. Biochem Med Metab Biol 50 (1993) 127-134
31. Sato H., Jordan J.E., Zhao Z.-Q., et al. Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation. Ann Thorac Surg 64 (1997) 1099-1107
32. Vinten-Johansen J., Lefer D.J., Nakanishi K., et al. Controlled coronary hydrodynamics at the time of reperfusion reduces postischemic injury. Coron Artery Dis 3 (1992) 1081-1093
33. Halkos M.E., Kerendi F., Corvera J.S., et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 78 (2004) 961-969
34. Zhao Z.-Q., Corvera J.S., Wang N.-P., et al. Reduction in infarct size and preservation of endothelial function by ischemic postconditioning: comparison with ischemic preconditioning. [abstract]. Circulation 106 19 (2002) II314
35. Darling C.E., Jiang R., Maynard M., et al. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol 289 (2005) H1618-H1626
36. Laskey W.K. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 65 (2005) 361-367
37. Dissmann R., Goerke M., von Ameln H., et al. Detection of early reperfusion and prediction of left ventricular damage from the course of increased ST values in acute myocardial infarct with thrombolysis. [in German]. Z Kardiol 82 (1993) 271-278
38. Feldman L.J., Himbert D., Juliard J.-M., et al. Reperfusion syndrome: relationship of coronary blood flow reserve to left ventricular function and infarct size. J Am Coll Cardiol 35 (2000) 1162-1169
39. Ito H., Tomooka T., Sakai N., et al. Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction. [see comments]. Circulation 87 (1993) 355-362
40. Kobayashi N., Ohmura N., Nakada I., et al. Further ST elevation at reperfusion by direct percutaneous transluminal coronary angioplasty predicts poor recovery of left ventricular systolic function in anterior wall AMI. Am J Cardiol 79 (1997) 862-866
41. Ochiai M., Isshiki T., Takeshita S., et al. Relation of duration of ST re-elevation at reperfusion and improvement of left ventricular function after successful primary angioplasty of the left anterior descending coronary artery in anterior wall acute myocardial infarction. Am J Cardiol 79 (1997) 1667-1670
42. Shah A., Wagner G.S., Granger C.B., et al. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. J Am Coll Cardiol 35 (2000) 666-672
43. Ito H., Okamura A., Iwakura K., et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 93 (1996) 1993-1999
44. Yellon D.M., and Baxter G.F. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?. Heart 83 (2000) 381-387
45. Vinten-Johansen J., Zhao Z.Q., Kerendi F., et al. Postconditioning: a new link in nature's armor against ischemia-reperfusion injury. [abstract]. J Mol Cell Cardiol 36 4 (2004) 637
46. 2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol 284 (2003) H566-H574
47. Ambrosio G., Zweier J.L., and Flaherty J.T. The relationship between oxygen radical generation and impairment of myocardial energy metabolism following post-ischemic reperfusion. J Mol Cell Cardiol 23 (1991) 1359-1374
48. Jolly S.R., Kane W.J., Bailie M.B., et al. Canine myocardial reperfusion injury: its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 54 (1984) 277-285
49. Bagchi D., Das D.K., Engelman R.M., et al. Polymorphonuclear leukocytes as potential source of free radicals in the ischaemic-reperfused myocardium. Eur Heart J 11 (1990) 800-813
50. Ko W., Hawes A.S., Lazenby W.D., et al. Myocardial reperfusion injury. Platelet-activating factor stimulates polymorphonuclear leukocyte hydrogen peroxide production during myocardial reperfusion. J Thorac Cardiovasc Surg 102 (1991) 297-308
51. Zhao Z.-Q., Corvera J.S., Halkos M.E., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285 (2003) 579-588
52. Kin H., Zhao Z.-Q., Sun H.-Y., et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62 (2004) 74-85
53. Zweier J.L., Flaherty J.T., and Weisfeldt M.L. Direct measurement of free radicals generated following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A 84 (1987) 1404-1407
54. Bolli R., Jeroudi M.O., Patel B.S., et al. Marked reduction of free radical generation and contractile dysfunction by antixoidant therapy begun at the time of reperfusion: evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res 65 (1989) 607-622
55. Dreyer W.J., Michael L.H., West M.W., et al. Neutrophil accumulation in ischemic canine myocardium: insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 84 (1991) 400-411
56. Dreyer W.J., Smith C.W., Michael L.H., et al. Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium. Circ Res 65 (1989) 1751-1762
57. Entman M.L., Michael L., Rossen R.D., et al. Inflammation in the course of early myocardial ischemia. FASEB J 5 (1991) 2529-2537
58. Lefer A.M., and Lefer D.J. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol 33 (1993) 71-90
59. Davenpeck K.L., Gauthier T.W., Albertine K.H., et al. Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. Am J Physiol 267 (1994) H622-H630
60. Kubes P., Jutila M., and Payne D. Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest 95 (1995) 2510-2519
61. Kubes P., Kurose I., and Granger D.N. NO donors prevent integrin-induced leukocyte adhesion but not P- selectin-dependent rolling in postischemic venules. Am J Physiol 267 (1994) H931-H937
62. Ley K. Molecular mechanisms of leukocyte rolling and adhesion to microvascular endothelium. [review]. Eur Heart J 14 Suppl I (1993) 68-73
63. Ley K., Tangelder G.J., and von Andrian U.H. Modulation of leukocyte rolling in vivo. In: Granger D.N., and Schmid-Schönbein G.W. (Eds). Physiology and pathophysiology of leukocyte adhesion (1995), Oxford University Press, New York 217-240
64. Ley K., and Tedder T.F. Leukocyte interactions with vascular endothelium. New insights into selectin-mediated attachment and rolling. J Immunol 155 (1995) 525-528
65. McEver R.P., and Cummings R.D. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 100 (1997) 485-492
66. Moore K.L., Patel K.D., Bruehl R.E., et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on p-selectin. J Cell Biol 128 (1995) 661-671
67. Lefer A.M., Ma X.-L., Weyrich A., et al. Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury. Agents Actions Suppl 41 (1993) 127-135
68. Albertine K.H., Weyrich A.S., Ma X.-L., et al. Quantification of neutrophil migration following myocardial ischemia and reperfusion in cats and dogs. J Leukoc Biol 55 (1994) 557-566
69. Boyle E.M., Pohlman T.H., Johnson M.C., et al. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg 63 (1997) 277-284
70. Dreyer W.J., Michael L.H., Millman E.E., et al. Neutrophil activation and adhesion molecule expression in a canine model of open heart surgery with cardiopulmonary bypass. Cardiovasc Res 29 (1995) 775-781
71. Dreyer W.J., Smith C.W., and Entman M.L. Invited letter concerning: neutrophil activation during cardiopulmonary bypass. J Thorac Cardiovasc Surg 102 (1991) 318-320
72. Gillinov A.M., Bator J.M., Zehr K.J., et al. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators. Ann Thorac Surg 56 (1993) 847-853
73. Gillinov A.M., DeValeria P.A., Winkelstein J.A., et al. Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass. Ann Thorac Surg 55 (1993) 619-624
74. Gillinov A.M., Redmond J.M., Winkelstein J.A., et al. Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog. Ann Thorac Surg 57 (1994) 345-352
75. Gillinov A.M., Redmond J.M., Zehr K.J., et al. Inhibition of neutrophil adhesion during cardiopulmonary bypass. Ann Thorac Surg 57 (1994) 126-133
76. Kawamura T., Wakusawa R., Okada K., et al. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. [see comments]. Can J Anaesth 40 (1993) 1016-1021
77. Levy J.H., and Kelly A.B. Inflammation and cardiopulmonary bypass. [editorial; comment]. Can J Anaesth 40 (1993) 1009-1015
78. Prasad K., Kalra J., Bharadwaj B., et al. Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery. Am Heart J 123 (1992) 37-45
79. Wilson I., Gillinov A.M., Curtis W.E., et al. Inhibition of neutrophil adherence improves postischemic ventricular performance of the neonatal heart. Circulation 88 (1993) II372-II379
80. Mohazzab K.M., Kaminski P.M., and Wolin M.S. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 266 (1994) H2568-H2572
81. + exchanger during ischemia and reperfusion. Cardiovasc Res 57 (2003) 934-941
82. Gross G.J., and Gumina R.J. Cardioprotective effects of Na+/H+ exchange inhibitors. Drugs of the Future 26 (2001) 253-260
83. Gumina R.J., Auchampach J.A., Wang R., et al. Na+/H+ exchange inhibition-induced cardioprotection in dogs: effects on neutrophils versus cardiomyocytes. Am J Physiol Heart Circ Physiol 279 (2000) H1563-H1570
84. + exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual blood flow. Circulation 102 (2000) 1977-1982
85. Hurtado C., and Pierce G.N. Sodium-hydrogen exchange inhibition: pre- versus post-ischemic treatment. Basic Res Cardiol 96 (2001) 312-317
86. Garcia-Dorado D., Gonzalez M.A., Barrabes J.A., et al. Prevention of ischemic rigor contracture during coronary occlusion by inhibition of Na+/H+ exchange. Cardiovasc Res 35 (1997) 80-89
87. Piper H.M. Energy deficiency, calcium overload or oxidative stress: possible causes of irreversible ischemic myocardial injury. Klin Wochenschr 67 (1989) 465-476
88. Piper H.M., and Garcia-Dorado D. Prime cause of rapid cardiomyocyte death during reperfusion. Ann Thorac Surg 68 (1999) 1913-1919
89. Piper H.M., Garcia-Dorado D., and Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 38 (1998) 291-300
90. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341 (1999) 233-249
91. Halestrap A.P., Kerr P.M., Javadov S., et al. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1366 (1998) 79-94
92. Cain B.S., Meldrum D.R., Dinarello C.A., et al. Adenosine reduces cardiac TNF-alpha production and human myocardial injury following ischemia-reperfusion. J Surg Res 76 2 (1998) 117-123
93. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol 274 (1998) R577-R595
94. Lucchesi B.R. Complement activation, neutrophils, and oxygen radicals in reperfusion injury. Stroke 24 (1993) I-41-I-47
95. Lucchesi B.R. Complement, neutrophils and free radicals: mediators of reperfusion injury. [review]. Arzneim-Forsch/Drug Res 44 (1994) 420-432
96. Piper H.M., and Schafer A.C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 61 (2004) 365-371
97. Zhao Z.-Q., Nakamura M., Wang N.-P., et al. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion. J Surg Res 94 (2000) 1-12
98. Philipp S.D., Downey J.M., and Cohen M.V. Postconditioning must be initiated in less than 1 minute following reperfusion and is dependent on adenosine receptors and P13-kinase. [abstract]. Circulation 110 17 (2004) III-168
99. Yang X.-M., Proctor J.B., Cui L., et al. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 44 (2004) 1103-1110
100. Coughlin S.R. Thrombin signaling and protease-activated receptors. Nature 407 (2000) 258-264
101. Sabri A., Muske G., Zhang H., et al. Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors. Circ Res 86 (2000) 1054-1061
102. Napoli C., Cicala C., Wallace J.L., et al. Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart. Proc Natl Acad Sci U S A 97 (2000) 3678-3683
103. Napoli C., De Nigris F., Wallace J.L., et al. Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions. J Clin Pathol 57 (2004) 513-516
104. Cirino G., Cicala C., Bucci M.R., et al. Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med 183 (1996) 821-827
105. Jobe L.J., Jiang R., Wang N.-P., et al. Tissue factor, factors VIIa and Xa expression and local generation of thrombin in at risk myocardium occurs specifically during reperfusion. Circulation 110 17 (2004) III-297
106. Fu J., Naren A.P., Gao X., et al. Protease-activated receptor-1 activation of endothelial cells induces protein kinase Cα-dependent phosphorylation of syntaxin 4 and Munc18c. J Biol Chem 280 (2005) 3178-3184
107. Golino P., Ragni M., Cirillo P., et al. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 2 (1996) 35-40
108. Grill H.P., Zweier J.L., Kuppusamy P., et al. Direct measurement of myocardial free radical generation in an in vivo model: effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase. J Am Coll Cardiol 20 (1992) 1604-1611
109. Golino P., Ragni M., Cirillo P., et al. Recombinanat human, active site-blocked factor VIIa reduces infarct size and the no-reflow phenomenon in rabbits. Am J Physiol Heart Circ Physiol 278 (2000) H1507-H1516
110. Erlich J.H., Boyle E.M., Santucci R.A., et al. Tissue factor upregulation in cardiomyocytes after ischemia/reperfusion. [abstract]. Am J Pathol 147 (2000) 37
111. Erlich J.H., Boyle E.M., Labriola J., et al. Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol 157 (2000) 1849-1862
112. Liu Y., Pelekanakis K., and Woolkalis M.J. Thrombin and tumor necrosis factor α synergistically stimulate tissue factor expression in human endothelial cells. J Biol Chem 279 (2004) 36142-36147
113. Mirabet M., Garcia-Dorado D., Ruiz-Meana M., et al. Thrombin increases cardiomyocyte acute cell death after ischemia and reperfusion. J Mol Cell Cardiol 39 (2005) 277-283
114. Gurevitch J., Barak J., Hochhauser E., et al. Aprotinin improves myocardial recovery after ischemia and reperfusion. Effects of the drug on isolated rat hearts. J Thorac Cardiovasc Surg 108 (1994) 109-118
115. Zimmerman B.J., and Granger N. Reperfusion-induced leukocyte infiltration: role of elastase. Am J Physiol 259 (1990) H390-H394
116. Hansen P.R., and Stawski G. Neutrophil mediated damage to isolated myocytes after anoxia and reoxygenation. Cardiovasc Res 28 (1994) 565-569
117. Sabri A., Alcott S.G., Elouardighi H., et al. Neutrophil cathepsin G promotes detachment-induced cardiomyocyte apoptosis via a protease-activated receptor-independent mechanism. J Biol Chem 278 (2003) 23944-23954
118. Vinten-Johansen J., Thourani V.H., Ronson R.S., et al. Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg 68 (1999) 1942-1948
119. Suzuki T., Moraes T.J., Vachon E., et al. Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol 33 (2005) 231-247
120. Miller T.D., Christian T.F., Hopfenspirger M.R., et al. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 92 (1995) 334-341
121. Pfeffer M.A., and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observation and clinical implications. Circulation 81 (1990) 1161-1172
122. Bolli R., Becker L., Gross G., et al. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 95 (2004) 125-134
123. Gheorghiade M., and Bonow R.O. Chronic heart failure in the United States. A manifestation of coronary artery disease. Circulation 97 (1998) 282-289
124. Massie B.M., and Shah N.B. Evolving trends in the epidemiologic factors of heart failure: rational for preventive strategies and comprehensive disease management. Am Heart J 133 (1997) 703-712
125. Sharpe N., and Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet 352 (1998) 3-7
126. Ho K.K., Anderson K.M., Kannel W.B., et al. Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88 (1993) 107-115
127. Yang F., Liu Y.H., Yang X.P., et al. Myocardial infarction and cardiac remodeling in mice. Exp Physiol 87 (2002) 547-555
128. Bolognese L., Neskovic A.N., Parodi G., et al. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 106 (2002) 2351-2357
129. Kin H., Zatta A.J., Lofye M.T., et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 67 (2005) 124-133
130. Johnson III G., Tsao P.S., Mulloy D., et al. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther 252 (1990) 35-41
131. Lefer D.J., Nakanishi K., Johnston W.E., et al. Anti-neutrophil and myocardial protecting action of SPM-5185, a novel nitric oxide (NO) donor, following acute myocardial ischemia and reperfusion in dogs. Circulation 88 (1993) 2337-2350
132. Nakanishi K., Vinten-Johansen J., Lefer D.J., et al. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 263 (1992) H1650-H1658
133. Weyrich A.S., Ma X.-L., and Lefer A.M. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86 (1992) 279-288
134. Engelman D.T., Watanabe M., Maulik N., et al. Critical timing of nitric oxide supplementation in cardioplegic arrest and reperfusion. Circulation 94 (1996) II-407-II-411
135. Ihnken K. Myocardial protection in hypoxic immature hearts. Thorac Cardiovasc Surg 48 (2000) 46-54
136. Nakanishi K., Zhao Z.-Q., Vinten-Johansen J., et al. Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction. J Thorac Cardiovasc Surg 109 (1995) 1146-1154
137. Beresewicz A., Karwatowska-Prokopczuk E., Lewartowski B., et al. A protective role of nitric oxide in isolated ischaemic reperfused rat heart. Cardiovasc Res 30 (1995) 1001-1008
138. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76 (1994) 5-13
139. Cronstein B.N., Kramer S.B., Weissmann G., et al. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 158 (1983) 1160-1177
140. 3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury. Am J Physiol 277 (1999) H1895-H1905
141. 2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exp Ther 280 (1997) 301-309
142. 2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium. Am J Physiol 271 (1996) H1456-H1464
143. Babbitt D.G., Virmani R., Vildibill Jr. H.D., et al. Intracoronary adenosine administration during reperfusion following 3 hours of ischemia: effects on infarct size, ventricular function, and regional myocardial blood flow. Am Heart J 120 (1990) 808-818
144. Muraki S., Morris C.D., Budde J.M., et al. Experimental off-pump coronary artery revascularization with adenosine-enhanced reperfusion. J Thorac Cardiovasc Surg 121 (2001) 570-579
145. Olafsson B., Forman M.B., Puett D.W., et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 76 (1987) 1135-1145
146. Royston D., Bidstrup B.P., Taylor K.M., et al. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 2 (1987) 1289-1291
147. Pruefer D., Buerke U., Khalili M., et al. Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart. J Thorac Cardiovasc Surg 124 (2002) 942-949
148. van Oeveren W., Jansen N.J.G., Bidstrup B., et al. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg 44 (1987) 640-645
149. Lord R.A., Roath O.S., Thompson J.F., et al. Effect of aprotinin on neutrophil function after major vascular surgery. Br J Surg 79 (1992) 517-521
150. Pruefer D., Makowski J., Dahm M., et al. Aprotinin inhibits leukocyte-endothelial cell interactions after hemorrhage and reperfusion. Ann Thorac Surg 75 (2003) 210-215
151. Reeves J.G., Mykytenko J., Jiang R., et al. Inhibition of serine protease activity at reperfusion attenuates reperfusion injury. [abstract]. J Mol Cell Cardiol 38 (2005) 830
152. McLean P.G., Aston D., Sarkar D., et al. Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers. Circ Res 90 (2002) 465-472
153. Lefer D.J., Nakanishi K., and Vinten-Johansen J. Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 22 Suppl 7 (1993) S34-S43
154. Lefer D.J., Shandelya S.M., Serrano Jr. C.V., et al. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury. Circulation 88 (1993) 1779-1787
155. Ziegelstein R.C., Corda S., Pili R., et al. Initial contact and subsequent adhesion of human neutrophils or monocytes to human aortic endothelial cells releases an endothelial intracellular calcium store. Circulation 90 (1994) 1899-1907
156. Feistritzer C., Lenta R., and Riewald M. Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling. J Thromb Haemost 3 (2005) 2798-2805